Boston, Massachusetts, Jan. 30, 2023 (GLOBE NEWSWIRE) -- #" HYCU Named to 2023 CRN Cloud 100 For fifth consecutive year, HYCU named to prestigious list for commitment to channel partners as wel...
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial 4-12-2024, 14:00